finanzen.net

52 Weeks Entertainment Aktie ISIN: INE545N01019

0,2600INR
+0,0300INR
+13,64%
06.12.2019
KAUFEN
VERKAUFEN
mehr Daten anzeigen

52 Weeks Entertainment Aktie Analyse

Es konnte keine Analyse gefunden werden

Aktuelle News zu

15:21 UhrBricht der US-Aktienmarkt um Weihnachten erneut ein?
15:10 UhrHow To Make Car Insurance Premiums More Affordable - New Guide
15:00 UhrHier stimmt was nicht! Uber könnte nun unten sein
15:00 UhrSierra Oncology Reports Decreased Transfusion Requirements for Patients Treated with Momelotinib Directly Compared to Ruxolitinib at ASH Annual Meeting
15:00 UhrMAIA Pharmaceuticals, Inc. Announces Soterius, Inc. As Its Trusted Partner
15:00 UhrALLPCB Accepted the Interview about "Domestic Products Go Global", Sharing Strategies for Non-Standard Industrial Products to Expand Global Market.
15:00 UhrMore than Seven-Year Analysis of Early Treatment with IMBRUVICA® (ibrutinib) Monotherapy Showed Improved Progression-Free Survival in Patients with Mantle Cell Lymphoma (MCL) that Relapsed or Were...
15:00 UhrSierra Oncology Reports Decreased Transfusion Requirements for Patients Treated with Momelotinib Directly Compared to Ruxolitinib at ASH Annual Meeting
15:00 UhrSangamo and Pfizer Announce Updated Phase 1/2 Results Showing Sustained Increased Factor VIII Activity Through 44 Weeks Following SB-525 Gene Therapy Treatment
14:58 UhrKW 49: Tops und Flops der TecDAX-Aktien in der vergangenen Woche
14:00 UhrCellular Biomedicine Group Presents First Clinical Data of IIT Phase 1 Trial of C-CAR088, a Novel BCMA CAR-T, at the 61st Annual Meeting of the American Society of Hematology
14:00 UhrStatement - Minister Garneau marks International Civil Aviation Day
14:00 UhrStatement - Minister Garneau marks International Civil Aviation Day
14:00 UhrAxcella Presents Data at ASH Annual Meeting
13:35 UhrIMBRUVICA® (ibrutinib) Combination Therapy Data From Two Studies and Long-Term Integrated Analysis Presented at ASH 2019 Show Efficacy and Safety in First-Line Treatment of Chronic Lymphocytic Leu...
13:33 UhrExtended Follow-up Phase 3 Data Underscore Sustained Efficacy and Safety of IMBRUVICA® (ibrutinib) in the Treatment of Chronic Lymphocytic Leukemia (CLL)
13:30 UhrJanssen Presents Initial Results for BCMA CAR-T Therapy JNJ-4528 Showing Early, Deep and High Responses in the Treatment of Relapsed or Refractory Multiple Myeloma
13:30 UhrIMBRUVICA® (ibrutinib) Plus VENCLEXTA®/VENCLYXTO® (venetoclax) Combination Data Show High Rates of Disease Clearance in Previously Untreated Patients with Chronic Lymphocytic Leukemia (CLL)
13:19 UhrVarta - das dürfen Sie erwarten
13:07 UhrWarum der Hoffnungsmarkt Cannabis an der Börse Milliarden an Marktkapitalisierung gekostet hat
13:01 UhrWirecard, Tesla, Thyssen - Adventskracher
13:00 UhrMoromix Company Releases Latest Lineup of Dermatological Resources
13:00 UhrIntelligent.com Announces Best Nutrition Degree Programs for 2020
13:00 UhrIntelligent.com Announces Best Master of Science in Nursing (MSN) Degree Programs for 2020
13:00 UhrIntelligent.com Announces Best Master's in Legal Studies Degree Programs for 2020
13:00 UhrIntelligent.com Announces Best Master's in Finance Degree Programs for 2020
13:00 UhrIntelligent.com Announces Best Master's in Business Analytics Degree Programs for 2020
13:00 Uhr/R E P E A T -- Invitation to the Media - Elected Officials and Stars Lend a Hand at Christmas Harvest/
12:00 UhrDer Nationalismus und der Mauerfall: Investmentlegende Soros zieht Bilanz
12:00 UhrIntelligent.com Announces Best Marketing Degree Programs for 2020
12:00 UhrIntelligent.com Announces Best Master's in Homeland Security Degree Programs for 2020
12:00 UhrIntelligent.com Announces Best Master's in Human Resources Degree Programs for 2020
12:00 UhrIntelligent.com Announces Best Human Services Degree Programs for 2020
12:00 UhrIntelligent.com Announces Best Doctorate in Psychology Degree Programs for 2020
12:00 UhrRankings.io Earns Spot on the Coveted Clutch 1,000 List: An Exclusive Award for B2B Service Providers Around the World
12:00 UhrCeribell Announces Launch Of Clarity, Providing 24/7 Automatic Bedside Monitoring To Enhance EEG Capability
11:00 UhrTruck Seals Manufacturer, American Casting & Manufacturing, Shares 4 Ways to Use Truck Seals
11:00 UhrStudent Travel Programs, Fantastic Tours & Travel, Gives Ideas for Last-Minute Fundraising
10:21 UhrTop-News der Woche: Diese Themen waren diese Woche wichtig
09:05 UhrXBiotech Announces Agreement to Sell True Human Antibody Bermekimab Targeting IL-1a to Janssen
09:05 UhrXBiotech Announces Agreement to Sell True Human Antibody Bermekimab Targeting IL-1a to Janssen
09:00 UhrTarnished Triumphs - New Study Looks at the Emotionally Corrosive Effect of Impostor Syndrome
09:00 UhrOrlando Office Solutions, LLC Set to Finalize Condo Sale for $550,000 in BMO Harris Bank Building
08:40 UhrJanssen to Acquire Investigational Bermekimab from XBiotech
08:00 UhrDAX, Gold, Öl und Aktien: Die wichtigsten News und Analysen auf Ihr Smartphone!
08:00 UhrDAX, Gold, Öl und Aktien: Die wichtigsten News und Analysen auf Ihr Smartphone!
08:00 UhrMegabörsengang: Aramco überholt Alibaba und Apple
07:55 UhrNeue Ausgabe von €uro am Sonntag: Ausblick 2020: Die Prognosen der Experten
07:42 UhrDer demografische Wandel in Zahlen
07:00 UhrDividende 2020: Diese DAX-Konzerne schütten am meisten aus

Online Brokerage über finanzen.net

finanzen.net Brokerage
Handeln Sie für nur 5 Euro Orderprovision* pro Trade aus der Informationswelt von finanzen.net!

ETF-Sparplan

Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.
Zur klassischen Ansicht wechseln
Kontakt - Impressum - Werben - Pressemehr anzeigen
Top News
Beliebte Suchen
DAX 30
Öl
Euro US-Dollar
Bitcoin
Goldpreis
Meistgesucht
Wirecard AG747206
Microsoft Corp.870747
Deutsche Bank AG514000
Daimler AG710000
Apple Inc.865985
Amazon906866
Infineon AG623100
NEL ASAA0B733
Allianz840400
CommerzbankCBK100
BASFBASF11
OSRAM AGLED400
EVOTEC SE566480
Ballard Power Inc.A0RENB
Deutsche Telekom AG555750